tiprankstipranks
Trending News
More News >

Lixte Biotechnology Appoints New Chief Medical Officer

Lixte Biotechnology Appoints New Chief Medical Officer

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Lixte Biotechnology Holdings (LIXT) is now available.

In a significant corporate update, the Company has announced the appointment of Dr. Jan Schellens as the new Chief Medical Officer, effective from June 3, 2024. This move could signal strategic shifts and expertise enhancement, capturing the attention of investors tracking leadership changes in the stock market.

Find detailed analytics on LIXT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1